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MOST OF TIIE CHEMICALS known to induce
cancers in man are also carcinogenic in ani-
mals; arsenic and benzene are the best-known
exceptions. The remaining carcinogens, active
in both man and animals, show a tendency
to affect common target organs such as the
lungs and bladder, but, for each chemical,
there are generally additional unshared target
organs, particularly in animals. Even when
there are common target sites for a given
carcinogen, there are usually important
differences, between man and animals, and
between different species and strains of
animals. Such differences include variations
in the histology and growth pattern of the
tumours and their antecedent lesions, which
are likely to reflect different modes of expo-
sure ofthe target organ to the carcinogen with
respect to dose, route of administration, and
species-determined variations in pharmaco-
kinetics and metabolism. Thus for aromatic
amines the bladder is a shared target organ
in man and dog (and to some extent the
hamster). The common laboratory rodents
appear relatively resistant to the carcino-
genic effects of these compounds at most
potential target sites. The bladder tumours
induced in man and in dogs carry no distinct
pathological stigma and they vary between
the two species in terms oftheir histology and
growth pattern, the canine tumours being
low-grade non-metastasizing lesions. By con-
trast, several experimental species are suscep-
tible to the lung carcinogens which are also
active in man. The asbestos-induced pleural
mesotheliomas are closely similar in histology
and growth patterns, but the pathology of
lung carcinomas is more divergent. The
closest analogies are seen between man and
rat. Both develop histologically similar
squamous carcinomas and adenocarcinomas,
though the anaplastic small-cell carcinomas
of man have no definite counterpart. The
growth patterns of these tumours are differ-
ent, and rats (unlike man) seem to be more
prone to develop adenocarcinomas in response
to inhaled carcinogens.
Human tumours may provide aetiological
clues, particularly neoplasms which are rare
with respect to site and/or histology;
examples include adenocarcinomas of the
paranasal sinuses, clear-cell adenocarcinomas
of the vagina, hepatic angiosarcomas and
mesotheliomas. The vinyl chloride-associated
hepatic angiosarcomas could have been
predicted from previous animal experiments,
together with certain other tumours, but for
most compounds so far examined the carcino-
genic effects are confined to one or more ex-
perimental species unsupported by data in
humans. The crucial question is, therefore,
"To what extent can such tumours be used
to predict likely carcinogenic hazards for
man?" Potent animal carcinogens such as the
N-nitroso compounds or aflatoxin present no
problems. The difficulties arise with com-
pounds which act on a single target organ in
only one species, giving rise to "debatable
lesions" (vide infra) that co-exist (often in the
same organ) with a fluctuating incidence of
background "spontaneous" tumours. These
"spontaneous" tumours in rats and mice
develop principally in the breast, liver, lungs,
lympho-haemopoietic system and endocrine
glands. They have no distinctive pathological
features which allow them to be recognized
as "spontaneous" neoplasms and, for each
site, their incidence varies widely according
to sex, strain, diet, conditions of main-
tenance, hormonal status immunological
status and latent virus infections. The super-
imposed "debatable lesions" consist of non-
invasive nodules, "papillomas" and various
cellular dysplasias and atypias. Each ofthem
raises controversial points with respect to
origin and development, specificity vis-a-vis
the carcinogenic process, true malignant
potential and nomenclature. The limitations
of conventional pathological approaches
become particularly evident at this point and
better methods, particularly to analyse
mechanisms, are essential if improvements
are to be made in the predictive value of
animal tumours as a means of identifying
potential carcinogenic hazards for maii.
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